according to below, next to no subset of biopharma has been immune the last couple of months (ignoring Feb) from heavy pull backs. On the other hand, the top 500 biotechs are becoming increasingly cashed up. Hopefully macro side of things calms down coinciding with positive news flow over the next 12 months into a hungry Biotech M & A sector.
General Comments / Chat, page-5302
-
- There are more pages in this discussion • 6,599 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.53 |
Change
-0.060(3.77%) |
Mkt cap ! $260.7M | |||
| Open | High | Low | Value | Volume |
| $1.59 | $1.59 | $1.53 | $83.43K | 53.65K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 20575 | $1.53 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.57 | 300 | 1 |
View Market Depth
| Last trade - 16.10pm 16/10/2024 (20 minute delay) ? |
| RAC (ASX) Chart |